These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 984787)

  • 21. Pharmacokinetics of oral cephradine in continuous ambulatory peritoneal dialysis patients.
    Johnson CA; Welling PG; Zimmerman SW
    Nephron; 1984; 38(1):57-61. PubMed ID: 6472532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of intravenous cefotaxime in patients undergoing chronic hemodialysis.
    Chodos J; Francke EL; Saltzman M; Neu HC
    Ther Drug Monit; 1981; 3(1):71-4. PubMed ID: 6262952
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ceforanide kinetics in renal insufficiency.
    Hawkins SS; Alford RH; Stone WJ; Smyth RD; Pfeffer M
    Clin Pharmacol Ther; 1981 Oct; 30(4):468-74. PubMed ID: 7285481
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetic disposition of cefonicid in patients with renal failure and receiving hemodialysis.
    Barriere SL; Gambertoglio JG; Alexander DP; Stagg RJ; Conte JE
    Rev Infect Dis; 1984; 6 Suppl 4():S809-15. PubMed ID: 6522922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of ornidazole in patients with renal insufficiency; influence of haemodialysis and peritoneal dialysis.
    Merdjan H; Baumelou A; Diquet B; Chick O; Singlas E
    Br J Clin Pharmacol; 1985 Feb; 19(2):211-7. PubMed ID: 3986079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro activity and pharmacokinetics in patients of cefamandole, a new cephalsoporin antibiotic.
    Shemonsky NK; Carrizosa J; Levison ME
    Antimicrob Agents Chemother; 1975 Dec; 8(6):679-83. PubMed ID: 1211920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic modeling of bidirectional transfer during peritoneal dialysis.
    Janicke DM; Morse GD; Apicella MA; Jusko WJ; Walshe JJ
    Clin Pharmacol Ther; 1986 Aug; 40(2):209-18. PubMed ID: 3731683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peritoneal transport of cefonicid.
    Morse GD; Lane T; Nairn DK; Deterding J; Curry J; Gal P
    Antimicrob Agents Chemother; 1987 Feb; 31(2):292-4. PubMed ID: 3566253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of tobramycin in patients with stable renal impairment, patients undergoing peritoneal dialysis, and patients on chronic hemodialysis.
    Jaffe G; Meyers BR; Hirschman SZ
    Antimicrob Agents Chemother; 1974 Jun; 5(6):611-6. PubMed ID: 15825414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of moxalactam in patients with renal failure and during hemodialysis.
    Srinivasan S; Neu HC
    Antimicrob Agents Chemother; 1981 Sep; 20(3):398-400. PubMed ID: 6458236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of hemodialysis on piperacillin pharmacokinetics.
    Heim-Duthoy KL; Halstenson CE; Abraham PA; Matzke GR
    Int J Clin Pharmacol Ther Toxicol; 1986 Dec; 24(12):680-4. PubMed ID: 3818147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of hemodialysis and renal failure on serum and urine concentrations of cephapirin sodium.
    McCloskey RV; Terry EE; McCracken AW; Sweeney MJ; Forland MF
    Antimicrob Agents Chemother; 1972 Feb; 1(2):90-3. PubMed ID: 4680808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of cidofovir in renal insufficiency and in continuous ambulatory peritoneal dialysis or high-flux hemodialysis.
    Brody SR; Humphreys MH; Gambertoglio JG; Schoenfeld P; Cundy KC; Aweeka FT
    Clin Pharmacol Ther; 1999 Jan; 65(1):21-8. PubMed ID: 9951427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of cefoperazone in normal volunteers and subjects with renal insufficiency.
    Bolton WK; Scheld WM; Spyker DA; Sande MA
    Antimicrob Agents Chemother; 1981 May; 19(5):821-5. PubMed ID: 6457558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of renal failure and dialysis on the serum concentration of the aminoglycoside amikacin.
    Madhavan T; Yaremchuk K; Levin N; Pohlod D; Burch K; Fisher E; Cox F; Quinn EL
    Antimicrob Agents Chemother; 1976 Sep; 10(3):464-6. PubMed ID: 984789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of amikacin during hemodialysis and peritoneal dialysis.
    Regeur L; Colding H; Jensen H; Kampmann JP
    Antimicrob Agents Chemother; 1977 Feb; 11(2):214-8. PubMed ID: 848923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single-dose pharmacokinetics of cefpirome in patients receiving hemodialysis and in patients treated by continuous ambulatory peritoneal dialysis.
    Veys N; Lameire N; Malerczyk V; Lehr KH; Rosenkranz B; Ringoir S
    Clin Pharmacol Ther; 1993 Oct; 54(4):395-401. PubMed ID: 8222482
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of impaired renal function, hemodialysis, and peritoneal dialysis on the pharmacokinetics of mezlocillin.
    Kampf D; Schurig R; Weihermüller K; Förster D
    Antimicrob Agents Chemother; 1980 Jul; 18(1):81-7. PubMed ID: 6448024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of cefprozil in healthy subjects and patients with renal impairment.
    Shyu WC; Pittman KA; Wilber RB; Matzke GR; Barbhaiya RH
    J Clin Pharmacol; 1991 Apr; 31(4):362-71. PubMed ID: 2037710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of cefadroxil in normal subjects and in patients with renal insufficiency.
    Humbert G; Leroy A; Fillastre JP; Godin M
    Chemotherapy; 1979; 25(4):189-95. PubMed ID: 456077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.